Black Diamond Therapeutics Inc (BDTX)

Currency in USD
2.77
+0.23(+9.06%)
Closed·
2.770.00(0.00%)
·
BDTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BDTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.562.79
52 wk Range
1.206.75
Key Statistics
Prev. Close
2.77
Open
2.6
Day's Range
2.56-2.79
52 wk Range
1.2-6.75
Volume
1.68M
Average Volume (3m)
1.13M
1-Year Change
-48.32%
Book Value / Share
2.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BDTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.25
Upside
+270.04%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Black Diamond Therapeutics Inc Company Profile

Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company’s lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in Phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Compare BDTX to Peers and Sector

Metrics to compare
BDTX
Peers
Sector
Relationship
P/E Ratio
10.9x−1.2x−0.5x
PEG Ratio
0.09−0.040.00
Price/Book
1.2x2.7x2.6x
Price / LTM Sales
2.3x8.5x3.3x
Upside (Analyst Target)
279.1%301.4%40.3%
Fair Value Upside
Unlock20.0%4.7%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.25
(+270.04% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.19 / -0.2467
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BDTX Income Statement

People Also Watch

20.40
SRPT
+8.51%
5.09
REPL
-3.05%
2.56
INMB
+5.79%
3.74
ALT
+3.31%
11.980
COGT
+3.72%

FAQ

What Stock Exchange Does Black Diamond Trade On?

Black Diamond is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Black Diamond?

The stock symbol for Black Diamond is "BDTX."

What Is the Black Diamond Market Cap?

As of today, Black Diamond market cap is 157.71M.

What Is Black Diamond's Earnings Per Share (TTM)?

The Black Diamond EPS (TTM) is 0.25.

When Is the Next Black Diamond Earnings Date?

Black Diamond will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is BDTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Black Diamond Stock Split?

Black Diamond has split 0 times.

How Many Employees Does Black Diamond Have?

Black Diamond has 24 employees.

What is the current trading status of Black Diamond (BDTX)?

As of 14 Aug 2025, Black Diamond (BDTX) is trading at a price of 2.77, with a previous close of 2.77. The stock has fluctuated within a day range of 2.56 to 2.79, while its 52-week range spans from 1.20 to 6.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.